Philip Morris International Announces Closing of Fertin Pharma Acquisition; Advances PMI’s Goal of Becoming a Majority Smoke-Free Business by 2025 and Creates Growth Opportunities Beyond Nicotine

Philip Morris International Announces Closing of Fertin Pharma Acquisition; Advances PMI’s Goal of Becoming a Majority Smoke-Free Business by 2025 and Creates Growth Opportunities Beyond Nicotine

NEW YORK–(BUSINESS WIRE)–Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) today announced the closing of its acquisition of Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative pharmaceutical and well-being…

Click here to view the original article.

Business Wire, Global

Share this article

BTC, ETH, XRP, SOL Soar Despite US Government Shutdown

February 14, 2026

Is It Time To Reassess CACI International (CACI) After Recent Share Price Pullback?

February 14, 2026

Is Bitcoin Still the Best Cryptocurrency to Buy After This Sell-Off?

February 14, 2026

Navigating A 37.70% Potential Upside In Biotechnology

February 14, 2026

XRP Gains 3.3% As Capital Flows Back Into Crypto

February 14, 2026

A Biotech Gem With 57% Potential Upside

February 14, 2026

Trump-Linked Truth Social Furthers Push Into Crypto With Two New ETF Filings Tied To Bitcoin, Ether, And Cronos ⋆ ZyCrypto

February 14, 2026

Evaluating A 34.51% Upside Potential In The Diagnostics Sector

February 14, 2026